Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04543539 · ClinicalTrials.gov registry record
IN.PACT™ AV Access Post-Approval Study (PAS002)
A clinical trial of Arteriovenous Fistula and Fistula, sponsored by Medtronic.
- Active
- Registry status
- 240
- Enrollment target
- 20
- Study locations
NCT04543539 is a study of Arteriovenous Fistula and Fistula that is active but no longer recruiting, run by Medtronic. The registered enrollment target is 240 participants, roughly in line with the 230-participant average among 7 other Arteriovenous Fistula trials with a reported enrollment target. The trial reports 20 study locations across 15 states.
The verdict
NCT04543539, a study of Arteriovenous Fistula and Fistula, is active but no longer recruiting, sponsored by Medtronic.
- ACTIVE NOT RECRUITING
- Registry status
- 240 participants
- Enrollment target
- 20
- Study locations
Study Summary
Long-term safety will be summarized
Conditions Studied
Interventions
- COMBINATION_PRODUCT IN.PACT™ AV Drug Coated Balloon (DCB) - Primary Cohort
- COMBINATION_PRODUCT IN.PACT™ AV Drug Coated Balloon (DCB) - Extended Cohort
Study Locations (20)
New York
- Albany Medical College - Albany
- The Mount Sinai Hospital - New York
- Staten Island University Hospital - Staten Island
California
- Cedars-Sinai Heart Institute - Los Angeles
- Stanford University Medical Center - Stanford
Florida
- NCH Healthcare System - Naples
- Coastal Vascular and Interventional - Pensacola
South Carolina
- MUSC Health Dialysis Access Institute - Orangeburg
- Spartanburg Regional Medical Center - Spartanburg
Connecticut
- Yale New Haven Hospital - New Haven
District of Columbia
- Medstar Washington Hospital - Washington D.C.
Iowa
- University of Iowa - Iowa City
Michigan
- University of Michigan Health System - University Hospital - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2020-11-13 |
| Est. Completion | 2029-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04543539
The ClinicalTrials.gov registry entry for NCT04543539 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 230-participant average among 7 other Arteriovenous Fistula trials with a reported enrollment target. The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Arteriovenous Fistula appearing as the primary indexed condition, and to 2 interventions - of which IN.PACT™ AV Drug Coated Balloon (DCB) - Primary Cohort is the first listed.
NCT04543539 reports 20 study locations spanning 15 distinct geographic areas - top geographies include New York, California, Florida.
Frequently Asked Questions
What is clinical trial NCT04543539 about?
NCT04543539 is a clinical study titled "IN.PACT™ AV Access Post-Approval Study (PAS002)". Long-term safety will be summarized
What is the current status of trial NCT04543539?
This trial is currently active not recruiting. The enrollment target is 240 participants. The study started on 2020-11-13. Estimated completion is 2029-02.
What conditions does trial NCT04543539 study?
This clinical trial studies the following conditions: Arteriovenous Fistula, Fistula, Arteriovenous Fistula Stenosis, Arteriovenous Fistula Occlusion.
What interventions are being tested in trial NCT04543539?
The interventions under investigation include: IN.PACT™ AV Drug Coated Balloon (DCB) - Primary Cohort (COMBINATION_PRODUCT), IN.PACT™ AV Drug Coated Balloon (DCB) - Extended Cohort (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04543539?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04543539 being conducted?
This trial has 20 study locations across California, Connecticut, District of Columbia, Florida, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arteriovenous Fistula
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Pivotal Study of the Velocity™ pAVF System
RECRUITING · NA
-
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
RECRUITING · NA
-
Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae
ACTIVE NOT RECRUITING · NA
-
Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae
ACTIVE NOT RECRUITING · NA
-
Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.